Revenues in USD of Pelthos Therapeutics Inc. for Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Pelthos Therapeutics Inc. quarterly Revenues history and change rate for Q3 2025.
  • Pelthos Therapeutics Inc. Revenues for the quarter ending 30 Sep 2025 was $7.41M.
Revenues, Quarterly (USD)

Pelthos Therapeutics Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $7.41M 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.